Skip to main content
Premium Trial:

Request an Annual Quote

GenomOncology, Vanderbilt-Ingram to Improve Genomic Tool for Cancer Management

NEW YORK (GenomeWeb News) – GenomOncology and Vanderbilt-Ingram Cancer Center today announced they are partnering to develop a new genomics content management tool that will enable actionable results directed at cancer more quickly.

The tool will be based on Vanderbilt-Ingram's My Cancer Genome and will be developed to enhance the knowledge resource to enable "automated interpretation of mutations in the genome of a patient's tumor, providing actionable results in hours versus days," GenomOncology and Vanderbilt-Ingram said. The website will remain free and open to the public.

In addition, commercial uses of My Cancer Genome will be licensed through GenomOncology, the partners said.

The knowledge resource was launched by Vanderbilt-Ingram in 2011 to help physicians and researchers keep abreast of developments in precision cancer medicine and connect with clinical research trials. Through the web-based tool, clinicians can get information on the "rapidly expanding list of genetic mutations that impact cancers," the partners said.

"A resource like My Cancer Genome that matches tumor mutations to therapies and makes information accessible and convenient is an incredibly valuable tool," GenomOncology President and CEO Manuel Glynias said in a statement. "Our collaboration with Vanderbilt-Ingram Cancer Center on My Cancer Genome is designed to keep this resource comprehensive, scalable, and easy for clinicians to use."

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.